What is the pathophysiology of dengue shock syndrome?

Pathophysiology of Dengue Shock Syndrome

Dengue shock syndrome results from a transient capillary leak syndrome driven by immune-mediated endothelial dysfunction, leading to profound plasma leakage, hypovolemia, and ultimately circulatory collapse—a process that evolves through distinct temporal phases with both vascular and myocardial components.

Core Pathophysiologic Mechanisms

Vascular Permeability and Plasma Leakage

The hallmark of dengue shock syndrome is sudden vascular hyperpermeability characterized by thrombocytopenia, plasma leakage, and bleeding 1, 2. This process is defined by:

• Hemoconcentration (hematocrit increased by ≥20%) or other objective evidence of increased capillary permeability 2
• Hypotension or narrow pulse pressure (≤20 mm Hg) 2
• Thrombocytopenia (≤100,000/mm³) 2

The vascular leak typically resolves within 48-72 hours of defervescence, creating a critical therapeutic window 3.

Immune-Mediated Endothelial Injury

The pathophysiology involves a complex cascade of cytokine release when T cells attack dengue-infected cells 4. Recent evidence demonstrates:

• Endothelial glycocalyx disruption during the febrile phase 3, 5
• Hyperinflammation as the central determinant of outcomes, with IL-6 and ferritin strongly associated with severity (IL-6: β 0.70, p<0.001; ferritin: β 0.45, p<0.001) 5
• Endothelial activation markers (Ang-2, sTie-2, VCAM-1) correlating with pulmonary vascular leak (Ang-2: R=0.33, p<0.001) 5
• Glycocalyx breakdown products (syndecan-1, hyaluronan, heparan sulfate) associated with organ dysfunction 5

Temporal Evolution: Phase-Dependent Pathology

The cardiovascular involvement evolves across distinct phases 3:

1. Febrile Phase: Direct viral myocardial effects and initial endothelial glycocalyx disruption
2. Critical Phase: Immune-mediated injury, peak vascular leak, and myocardial dysfunction
3. Recovery Phase: Vascular permeability resolves (48-72 hours), but myocardial dysfunction may persist for up to 2 weeks 3

This temporal dissociation between vascular leak resolution and persistent cardiac dysfunction creates significant management challenges 3.

Mixed Shock Phenotype

Dengue shock frequently reflects a mixed phenotype with approximately equal contributions of hypovolemic and cardiogenic shock 3. This is critical because:

• Aggressive fluid resuscitation appropriate for pure hypovolemic shock may exacerbate cardiac dysfunction and increase pulmonary edema risk 3
• Cardiac involvement occurs in 12-50% of hospitalized patients, with manifestations including arrhythmias, pericarditis, myocarditis, and deterioration in myocardial function 1
• The inflammatory response may trigger intracoronary thrombosis, acute myocardial infarction, coronary dissection, and intramural hematoma 1

Antibody-Dependent Enhancement

Sequential infection with a different dengue serotype results in more severe disease 1. The mechanism involves:

• Enhancing and cross-reactive neutralizing antibodies that regulate disease severity 4
• Classic DHF/DSS can arise during initial dengue infections in infants with low circulating maternal dengue antibodies, demonstrating that secondary T-cell responses are not exclusively causal 4

Auto-Antibody Mechanisms

Molecular mimicry of dengue virus proteins with self-antigens generates auto-antibodies that contribute to pathogenesis 6:

• Anti-coagulation factor antibodies inhibit the coagulation cascade and promote hyperfibrinolysis
• Anti-platelet antibodies contribute to thrombocytopenia
• Anti-endothelial cell antibodies mediate hepatic inflammation during severe infection

Clinical Implications

Warning Signs Preceding Shock

An increase in hematocrit ≥5% concurrent with a decrease in platelet count ≥50% compared to the previous day occurs 1-2 days prior to DSS development (sensitivity 60.71%, specificity 83.04%) 7. This quantifiable definition resolves the previous ambiguity around laboratory warning signs.

Fluid Management Considerations

The pathophysiology creates a narrow therapeutic window where 8:

• Initial aggressive crystalloid resuscitation is essential (>4L in first 24 hours for adults may be required) 8
• Colloid solutions are particularly important in children with severe dengue shock syndrome (pulse pressure <10 mmHg) 8
• However, prolonged colloid use (>4 hours) significantly increases respiratory compromise risk (OR 8.84, p<0.001) 9

Risk Stratification

Hyperinflammation markers predict mortality 5:

• All patients who died had pre-mortem ferritin ≥100,000 ng/ml
• IL-6 discriminated survivors from non-survivors at 48 hours
• These markers most strongly correlate with pulmonary vascular leakage severity

Key Clinical Pitfalls

1. Underdiagnosis of cardiac involvement: Only a small percentage of dengue patients receive cardiac evaluation, especially in endemic areas, despite cardiac abnormalities on echo being associated with adverse outcomes 1

2. Fluid overload in mixed shock: Failure to recognize the cardiogenic component leads to excessive fluid administration and pulmonary edema 3

3. Timing misinterpretation: Assuming vascular leak and myocardial dysfunction resolve simultaneously, when cardiac dysfunction may persist 1-2 weeks beyond leak resolution 3